A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 24,028 shares of MRVI stock, worth $132,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,028
Previous 26,294 8.62%
Holding current value
$132,154
Previous $188,000 5.85%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$6.84 - $9.73 $15,499 - $22,048
-2,266 Reduced 8.62%
24,028 $199,000
Q2 2024

Aug 12, 2024

SELL
$6.87 - $11.34 $146,832 - $242,369
-21,373 Reduced 44.84%
26,294 $188,000
Q1 2024

May 09, 2024

SELL
$5.11 - $8.76 $11,155 - $19,123
-2,183 Reduced 4.38%
47,667 $413,000
Q4 2023

Feb 08, 2024

BUY
$4.7 - $9.87 $137,385 - $288,509
29,231 Added 141.77%
49,850 $326,000
Q3 2023

Nov 07, 2023

BUY
$9.14 - $12.85 $10,693 - $15,034
1,170 Added 6.02%
20,619 $206,000
Q2 2023

Aug 09, 2023

BUY
$12.09 - $15.0 $9,853 - $12,225
815 Added 4.37%
19,449 $241,000
Q1 2023

May 08, 2023

BUY
$12.99 - $16.48 $16,419 - $20,830
1,264 Added 7.28%
18,634 $261,000
Q4 2022

Feb 07, 2023

BUY
$12.5 - $24.78 $122,062 - $241,976
9,765 Added 128.4%
17,370 $248,000
Q2 2022

Aug 04, 2022

SELL
$26.05 - $37.48 $22,429 - $32,270
-861 Reduced 10.17%
7,605 $216,000
Q1 2022

May 09, 2022

BUY
$24.46 - $40.92 $22,356 - $37,400
914 Added 12.1%
8,466 $299,000
Q4 2021

Feb 07, 2022

BUY
$35.0 - $45.94 $61,635 - $80,900
1,761 Added 30.41%
7,552 $300,000
Q3 2021

Nov 04, 2021

SELL
$36.8 - $60.62 $1,839 - $3,031
-50 Reduced 0.86%
5,791 $284,000
Q2 2021

Aug 06, 2021

BUY
$32.46 - $45.0 $189,598 - $262,845
5,841 New
5,841 $244,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.